| 000 | 01878 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513213611.0 | ||
| 264 | 0 | _c20001006 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0887-4476 | ||
| 024 | 7 |
_a10.1002/1098-2396(20000901)37:3<171::AID-SYN1>3.0.CO;2-R _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Kampen, J M | |
| 245 | 0 | 0 |
_aDopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. _h[electronic resource] |
| 260 |
_bSynapse (New York, N.Y.) _cSep 2000 |
||
| 300 |
_a171-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-Methyl-4-phenylpyridinium _xtoxicity |
| 650 | 0 | 4 |
_aAmphetamine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApomorphine _xpharmacology |
| 650 | 0 | 4 | _aAutoradiography |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCocaine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aCytoprotection _xphysiology |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 | _aMicroinjections |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 | _aNerve Tissue Proteins |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aMcGeer, E G | |
| 700 | 1 | _aStoessl, A J | |
| 773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 37 _gno. 3 _gp. 171-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1098-2396(20000901)37:3<171::AID-SYN1>3.0.CO;2-R _zAvailable from publisher's website |
| 999 |
_c10831608 _d10831608 |
||